Not provided
Not provided
Not provided
Not provided
Not provided
Sponsor terminated study early. Data collection was sufficient to adequately assess primary endpoint.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a post-market prospective, 1:1 randomized, multicenter non-inferiority study to compare the femoral broaching time for THA with the Anterior Advantage approach with KINCISE vs. without KINCISE. Follow-up will continue through 24 weeks post-op.
The primary endpoint is femoral broaching time (in minutes), which is collected intraoperatively. The primary objective is to demonstrate that femoral broaching time with KINCISE is non-inferior to femoral broaching time with manual instruments (not using KINCISE) when used in THA with Anterior Advantage.
Note: If non-inferiority is successfully demonstrated, then the study will be deemed to be successful, and a test for superiority of femoral broaching time will be conducted.
If the primary endpoint analysis successfully demonstrates non-inferiority of femoral broaching time, then the following three secondary objectives will be assessed with formal hypotheses, in order, under a gatekeeping strategy:
In addition, the following secondary endpoints do not have prospectively planned hypotheses; these will be summarized for both treatment groups:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Anterior Approach with KINCISE | Experimental | Anterior Approach THA using KINCISE(TM) Surgical Automated System |
|
| Anterior Approach without KINCISE | Active Comparator | Anterior Approach THA with a mallet (without KINCISE) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| KINCISE(TM) Surgical Automated System | Device | Uncemented Total Hip Arthroplasty via Anterior Approach with and without the KINCISE(TM) Surgical Automated System |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mean Femoral Broach Time | Mean femoral broach time (in minutes) was collected intraoperatively and begun at the time the box osteotome first enters the femoral canal and ended with seating of the final broach trial within the femoral canal. | Day 0 (operative day) |
| Measure | Description | Time Frame |
|---|---|---|
| Skin-to-skin Time | Skin-to-skin is the time (in minutes) duration of the surgery procedure. | Day 0 (operative day) |
| Number of Participants With Optimal Acetabular Cup Abduction Angle at Week 6 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Orthopedic Specialty Center of Northern California | Roseville | California | 95678 | United States | ||
Johnson & Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu/
Not provided
Not provided
Not provided
A total of 250 participants were enrolled in this study, out of which 7 participants withdrew study before assignment to any treatment. Hence, only 243 participants were included in the analysis.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Arm 1: KINCISE | Participants indicated to receive primary uncemented total hip arthroplasty (THA) underwent Anterior Advantage approach in THA using KINCISE surgical automated system. |
| FG001 | Arm 2: MALLET | Participants indicated to receive primary uncemented THA underwent Anterior Advantage approach in THA using MALLET (a surgical hammer like instrument, without KINCISE surgical automated system). |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
The safety population set consisted of all enrolled participants who signed the informed consent document and attempted treatment according to the actual treatment received.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Arm 1: KINCISE | Participants indicated to receive primary uncemented total hip arthroplasty (THA) underwent Anterior Advantage approach in THA using KINCISE surgical automated system. |
| BG001 | Arm 2: MALLET |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Mean Femoral Broach Time | Mean femoral broach time (in minutes) was collected intraoperatively and begun at the time the box osteotome first enters the femoral canal and ended with seating of the final broach trial within the femoral canal. | Per protocol population set consisted of all enrolled participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, and who did not have any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N' (number of participants analyzed) signifies participants who were evaluable for this outcome measure. | Posted | Mean | Standard Deviation | Minutes | Day 0 (operative day) |
|
From Baseline (Day 0) up to end of study (up to 31 months)
The safety population set consisted of all enrolled participants who signed the informed consent document and attempted treatment according to the actual treatment received.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Arm 1: KINCISE | Participants indicated to receive primary uncemented total hip arthroplasty (THA) underwent Anterior Advantage approach in THA using KINCISE surgical automated system. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Wound infection | Infections and infestations | MedDRA Version 22.0 | Systematic Assessment |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA Version 22.0 | Systematic Assessment |
Study was terminated early due to business decision and not related to any safety concerns.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| FRANCHISE MEDICAL DIRECTOR | DePuy Orthopaedics | 844-434-4210 | ClinicalTrialDisclosure@its.jnj.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Oct 4, 2021 | Jul 13, 2023 | Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | Jun 15, 2022 | Jul 13, 2023 | SAP_001.pdf |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| D001172 | Arthritis, Rheumatoid |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
1:1 Block Randomization
Not provided
Not provided
Not provided
Not provided
Number of participants with optimal acetabular cup (a socket of the hip joint) abduction angle (movement of the leg away from the midline of the body) within +/- 10 degree of plan at Week 6 was reported.
| At Week 6 (post operative) |
| Number of Participants With Optimal Acetabular Cup Version Angle at Week 6 | Number of participants with optimal acetabular cup (a socket of the hip joint) version angle (rotation of leg in hip joint) within +/- 10 degrees of plan at Week 6 was reported. | At Week 6 (post operative) |
| Change From Pre-operative Baseline in Harris Hip Score (HHS) at Weeks 6 and 24 | The HHS was developed for the assessment of the results of hip surgery. HHS was intended to evaluate various hip disabilities and methods of treatment in an adult population. It consisted of 10 items covering four domains: pain (1 item, 0-44 points), function ( 7 items [limb, support, distance walked, stairs, socks/shoes, sitting and public transportation], 0-47 points), deformity (1 item, 4 points) and range of hip motion (1 items, 5 points). HHS total score was the sum of 10 items scores and ranged from 0 (worse disability) to 100 (less disability). The higher score indicated better outcome for the participant. The scores were interpreted as follows: < 70 = poor, 70-79 = fair, 80-89 = good and 90-100 = excellent. Day 0 was the operative day. | Pre-operative baseline (6 months before operative day), 6 weeks and 24 weeks post-operative |
| Change From 6-week Post-surgery in Forgotten Joint Score (FJS-12) at Week 24 | The FJS was a 12 question form that asks the participants their level of awareness of their artificial joint in 12 scenarios commonly encountered in daily life. Response to each question was individually scored (0 to 4, where 0=never, 1=almost never, 2=seldom, 3=sometimes and 4=mostly) and summed to create a raw composite score that was normalized to a range of 0 to 100 with a higher score indicating a better outcome (high degree of forgetting the artificial joint in everyday life). | 6-week post-operative to 24 weeks post-operatively |
| Change From Pre-operative Baseline in European Quality of Life (EuroQol)-5 Dimension-5 Level (EQ-5D-5L) Heath State Index Total Score at Weeks 6 and 24 | EQ-5D-5L descriptive system comprises of 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels of perceived problems (1-no problem, 2-slight problems, 3-moderate problems, 4-severe problems, 5-extreme problems). The responses to 5 EQ-5D-5L dimensions were scored using a utility-weighted algorithm to derive an EQ-5D-5L health status index score between 0 (death) to 100 (full health). Higher score indicated better QoL. | Pre-operative baseline (6 months before operative day), 6 weeks and 24 weeks post-operative |
| Change From Pre-operative Baseline in EQ-5D-5L Visual Analog Scale (VAS) Total Score at Weeks 6 and 24 | EQ-5D-5L was a 2-part instrument for use as a measure of health outcome, designed for self-completion by respondents. It consists of EQ-5D-5L descriptive system and EQ VAS. The EQ VAS self-rating records the respondent's own assessment of his or her overall health status at the time of completion, on a vertical line VAS with scale of 0 (the worst health you can imagine) to 100 (the best health you can imagine). A higher score indicates better health and positive changes from baseline indicate improvement of health status. | Pre-operative baseline (6 months before operative day), 6 weeks and 24 weeks post-operative |
| Number of Participants With Pain (Groin, and Buttock) at Weeks 6 and 24 | Number of participants with pain (Groin, and Buttock) at Weeks 6 and 24 was reported. Participant's groin pain and buttock pain was reported either as none, mild, moderate, or severe. | Weeks 6 and 24 (post-operative) |
| Number of Participants With Post-operative Satisfaction With the Procedure at Weeks 6 and 24 | Number of participants with post-operative satisfaction with the procedure at Weeks 6 and 24 was reported. Participants were asked a question that "How satisfied do you anticipate you will be with this procedure?" and participant responded on a 5-point scale (1=extremely satisfied, 2=very satisfied, 3=moderately satisfied, 4=slightly satisfied, 5=not at all satisfied). Higher score indicated low post-operative satisfaction. | Weeks 6 and 24 (post-operative) |
| Number of Participants With Post-operative Functional Recovery at Week 6 | Participants were asked the following questions: "Can you walk without an aid?", "Do you drive?", "Can you perform basic activities of daily living without assistance?", "Can you perform light household duties?", "Can you perform moderate to heavy household duties?", "Can you go up and down a flight of stairs using a handrail?", "Can you put on socks/stockings without someone's assistance?", "Can you bend down to pick up an object on the floor?", "Can you stand up from a chair without assistance?", "Can you participate in leisure recreational activities?", "Do you work?" and "When were you first able to accomplish the primary goal you identified after surgery?". Participants were asked to respond either as "yes" or "No, because of study hip". Number of participants who reported response as "yes" at Week 6 were reported in this outcome measure. | Week 6 (post-operative) |
| Number of Participants With Radiographic Outcomes: Assessed on Acetabular Cup, Femoral Stem, Calcar Resorption and Calcar Fractur | Number of participants with radiographic outcomes (acetabular cup migration, acetabular cup radiolucency, acetabular cup progressive radiolucency, acetabular cup osteolysis, acetabular cup sclerotic lines, acetabular cup porous coating integrity, femoral stem subsidence, femoral stem radiolucency, femoral stem osteolysis, calcar resorption, calcar fracture, femoral stem tilt and femoral stem porous coating integrity) were reported. In this outcome measure, only those timepoints in which participants had data were reported. In this outcome measure, each radiographic outcome assessment was reported either as present or absent in the analyzed participants. | Weeks 6 and 24 (post-operative) |
| Number of Participants With Radiographic Outcomes: Femoral Stem Position | Number of participants with radiographic outcome (femoral stem position) were reported. Femoral stem position was assessed as neutral, varus and valgus. | Weeks 6 and 24 (post-operative) |
| Number of Participants With Radiographic Outcomes: Device/Anatomy Condition | Number of participants with radiographic outcome (device/anatomy condition) were reported. Assessments were reported as intact or not intact. | Weeks 6 and 24 (post-operative) |
| Number of Participants With Radiographic Outcomes: Heterotopic Ossification | Number of participants with radiographic outcome (heterotopic ossification) were reported. Ossification is defined as formation of extraskeletal bone in muscle and soft tissues. Heterotopic ossification is the presence of bone in soft tissue where bone normally does not exist. Heterotopic ossification was classified as Class 0, I, II, III and IV where Class 0 indicates "no evidence heterotopic bone formation", Class I indicates "islands of bone within the soft tissue about the hip", Class II indicates "bone spurs from the pelvis or proximal end of the femur, leaving at least a centimeter (cm) between opposing bone surfaces", Class III indicates "bone spurs from the pelvis or proximal end of the femur, reducing the space between opposing bone surfaces to less than 1 cm", and Class IV indicates "apparent bone ankylosis of the hip." | Weeks 6 and 24 (post-operative) |
| Radiographic Outcomes: Assessment of Acetabular Cup Version (Hip) and Acetabular Cup Inclination | Radiographic outcome was assessed on acetabular cup version (hip) and acetabular cup inclination and reported in this outcome measure. | Weeks 6 and 24 (post-operative) |
| Length of Hospital Stay After Index Total Hip Arthroplasty (THA) | Length of hospital stay (in days) after index THA was calculated from date of discharge minus date of surgery. | From operative day (Day 0) to date of discharge (any time from Day 0 to Day 5) |
| Number of Participants With Re-hospitalization During the Study | Number of participants with re-hospitalizations during the study was reported. | Day 0 (operative day) to Day 90 (post-operative) |
| Number of Participants With Narcotic Pain Medication Usage | Number of participants who received any narcotic pain medication to manage study hip pain was reported. | From post operation (Day 0) to Week 24 |
| Number of Participants With Post-operative Complications | Number of participants who experienced post-operative complication was reported. | Day 0 (operative day) up to Week 24 |
| Colorado Joint Replacement |
| Denver |
| Colorado |
| 80210 |
| United States |
| Capital Region Orthopaedic Group | Albany | New York | 12208 | United States |
| Hospital for Special Surgery | New York | New York | 10021 | United States |
| Columbia University Medical Center | New York | New York | 10032 | United States |
| Carolina Orthopaedic & Sports Medicine | Gastonia | North Carolina | 28054 | United States |
| Southern Joint Replacement Institute | Nashville | Tennessee | 37203 | United States |
| Texas Institute for Hip and Knee Surgery | Austin | Texas | 78751 | United States |
| W.B. Carrell Memorial Clinic | Dallas | Texas | 75231 | United States |
| North Texas Medical Research Institute | Dallas | Texas | 75254 | United States |
| Jordan-Young Institute | Virginia Beach | Virginia | 23462 | United States |
| Physician Decision |
|
| Lost to Follow-up |
|
| Death |
|
Participants indicated to receive primary uncemented THA underwent Anterior Advantage approach in THA using MALLET (a surgical hammer like instrument, without KINCISE surgical automated system).
| BG002 | Total | Total of all reporting groups |
| Years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| OG001 | Arm 2: MALLET | Participants indicated to receive primary uncemented THA underwent Anterior Advantage approach in THA using MALLET (a surgical hammer like instrument, without KINCISE surgical automated system). |
|
|
|
| Secondary | Skin-to-skin Time | Skin-to-skin is the time (in minutes) duration of the surgery procedure. | Per protocol population set consisted of all enrolled participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, and who did not have any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. | Posted | Mean | Standard Deviation | Minutes | Day 0 (operative day) |
|
|
|
|
| Secondary | Number of Participants With Optimal Acetabular Cup Abduction Angle at Week 6 | Number of participants with optimal acetabular cup (a socket of the hip joint) abduction angle (movement of the leg away from the midline of the body) within +/- 10 degree of plan at Week 6 was reported. | Per protocol population set consisted of all enrolled participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, and who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N' (number of participants analyzed) signifies participants who were evaluable for this outcome measure. | Posted | Count of Participants | Participants | At Week 6 (post operative) |
|
|
|
| Secondary | Number of Participants With Optimal Acetabular Cup Version Angle at Week 6 | Number of participants with optimal acetabular cup (a socket of the hip joint) version angle (rotation of leg in hip joint) within +/- 10 degrees of plan at Week 6 was reported. | Per protocol population set consisted of all enrolled participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, and who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N' (number of participants analyzed) signifies participants who were evaluable for this outcome measure. | Posted | Count of Participants | Participants | At Week 6 (post operative) |
|
|
|
| Secondary | Change From Pre-operative Baseline in Harris Hip Score (HHS) at Weeks 6 and 24 | The HHS was developed for the assessment of the results of hip surgery. HHS was intended to evaluate various hip disabilities and methods of treatment in an adult population. It consisted of 10 items covering four domains: pain (1 item, 0-44 points), function ( 7 items [limb, support, distance walked, stairs, socks/shoes, sitting and public transportation], 0-47 points), deformity (1 item, 4 points) and range of hip motion (1 items, 5 points). HHS total score was the sum of 10 items scores and ranged from 0 (worse disability) to 100 (less disability). The higher score indicated better outcome for the participant. The scores were interpreted as follows: < 70 = poor, 70-79 = fair, 80-89 = good and 90-100 = excellent. Day 0 was the operative day. | Per protocol population set consisted of all enrolled participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Mean | Standard Deviation | Units on a scale | Pre-operative baseline (6 months before operative day), 6 weeks and 24 weeks post-operative |
|
|
|
| Secondary | Change From 6-week Post-surgery in Forgotten Joint Score (FJS-12) at Week 24 | The FJS was a 12 question form that asks the participants their level of awareness of their artificial joint in 12 scenarios commonly encountered in daily life. Response to each question was individually scored (0 to 4, where 0=never, 1=almost never, 2=seldom, 3=sometimes and 4=mostly) and summed to create a raw composite score that was normalized to a range of 0 to 100 with a higher score indicating a better outcome (high degree of forgetting the artificial joint in everyday life). | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N' (number of participants analyzed)=who were evaluable for this outcome measure. | Posted | Mean | Standard Deviation | Units on a scale | 6-week post-operative to 24 weeks post-operatively |
|
|
|
| Secondary | Change From Pre-operative Baseline in European Quality of Life (EuroQol)-5 Dimension-5 Level (EQ-5D-5L) Heath State Index Total Score at Weeks 6 and 24 | EQ-5D-5L descriptive system comprises of 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels of perceived problems (1-no problem, 2-slight problems, 3-moderate problems, 4-severe problems, 5-extreme problems). The responses to 5 EQ-5D-5L dimensions were scored using a utility-weighted algorithm to derive an EQ-5D-5L health status index score between 0 (death) to 100 (full health). Higher score indicated better QoL. | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Mean | Standard Deviation | Units on a scale | Pre-operative baseline (6 months before operative day), 6 weeks and 24 weeks post-operative |
|
|
|
| Secondary | Change From Pre-operative Baseline in EQ-5D-5L Visual Analog Scale (VAS) Total Score at Weeks 6 and 24 | EQ-5D-5L was a 2-part instrument for use as a measure of health outcome, designed for self-completion by respondents. It consists of EQ-5D-5L descriptive system and EQ VAS. The EQ VAS self-rating records the respondent's own assessment of his or her overall health status at the time of completion, on a vertical line VAS with scale of 0 (the worst health you can imagine) to 100 (the best health you can imagine). A higher score indicates better health and positive changes from baseline indicate improvement of health status. | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Mean | Standard Deviation | Units on a scale | Pre-operative baseline (6 months before operative day), 6 weeks and 24 weeks post-operative |
|
|
|
| Secondary | Number of Participants With Pain (Groin, and Buttock) at Weeks 6 and 24 | Number of participants with pain (Groin, and Buttock) at Weeks 6 and 24 was reported. Participant's groin pain and buttock pain was reported either as none, mild, moderate, or severe. | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Count of Participants | Participants | Weeks 6 and 24 (post-operative) |
|
|
|
| Secondary | Number of Participants With Post-operative Satisfaction With the Procedure at Weeks 6 and 24 | Number of participants with post-operative satisfaction with the procedure at Weeks 6 and 24 was reported. Participants were asked a question that "How satisfied do you anticipate you will be with this procedure?" and participant responded on a 5-point scale (1=extremely satisfied, 2=very satisfied, 3=moderately satisfied, 4=slightly satisfied, 5=not at all satisfied). Higher score indicated low post-operative satisfaction. | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Count of Participants | Participants | Weeks 6 and 24 (post-operative) |
|
|
|
| Secondary | Number of Participants With Post-operative Functional Recovery at Week 6 | Participants were asked the following questions: "Can you walk without an aid?", "Do you drive?", "Can you perform basic activities of daily living without assistance?", "Can you perform light household duties?", "Can you perform moderate to heavy household duties?", "Can you go up and down a flight of stairs using a handrail?", "Can you put on socks/stockings without someone's assistance?", "Can you bend down to pick up an object on the floor?", "Can you stand up from a chair without assistance?", "Can you participate in leisure recreational activities?", "Do you work?" and "When were you first able to accomplish the primary goal you identified after surgery?". Participants were asked to respond either as "yes" or "No, because of study hip". Number of participants who reported response as "yes" at Week 6 were reported in this outcome measure. | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Count of Participants | Participants | Week 6 (post-operative) |
|
|
|
| Secondary | Number of Participants With Radiographic Outcomes: Assessed on Acetabular Cup, Femoral Stem, Calcar Resorption and Calcar Fractur | Number of participants with radiographic outcomes (acetabular cup migration, acetabular cup radiolucency, acetabular cup progressive radiolucency, acetabular cup osteolysis, acetabular cup sclerotic lines, acetabular cup porous coating integrity, femoral stem subsidence, femoral stem radiolucency, femoral stem osteolysis, calcar resorption, calcar fracture, femoral stem tilt and femoral stem porous coating integrity) were reported. In this outcome measure, only those timepoints in which participants had data were reported. In this outcome measure, each radiographic outcome assessment was reported either as present or absent in the analyzed participants. | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Count of Participants | Participants | Weeks 6 and 24 (post-operative) |
|
|
|
| Secondary | Number of Participants With Radiographic Outcomes: Femoral Stem Position | Number of participants with radiographic outcome (femoral stem position) were reported. Femoral stem position was assessed as neutral, varus and valgus. | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Count of Participants | Participants | Weeks 6 and 24 (post-operative) |
|
|
|
| Secondary | Number of Participants With Radiographic Outcomes: Device/Anatomy Condition | Number of participants with radiographic outcome (device/anatomy condition) were reported. Assessments were reported as intact or not intact. | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Count of Participants | Participants | Weeks 6 and 24 (post-operative) |
|
|
|
| Secondary | Number of Participants With Radiographic Outcomes: Heterotopic Ossification | Number of participants with radiographic outcome (heterotopic ossification) were reported. Ossification is defined as formation of extraskeletal bone in muscle and soft tissues. Heterotopic ossification is the presence of bone in soft tissue where bone normally does not exist. Heterotopic ossification was classified as Class 0, I, II, III and IV where Class 0 indicates "no evidence heterotopic bone formation", Class I indicates "islands of bone within the soft tissue about the hip", Class II indicates "bone spurs from the pelvis or proximal end of the femur, leaving at least a centimeter (cm) between opposing bone surfaces", Class III indicates "bone spurs from the pelvis or proximal end of the femur, reducing the space between opposing bone surfaces to less than 1 cm", and Class IV indicates "apparent bone ankylosis of the hip." | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Count of Participants | Participants | Weeks 6 and 24 (post-operative) |
|
|
|
| Secondary | Radiographic Outcomes: Assessment of Acetabular Cup Version (Hip) and Acetabular Cup Inclination | Radiographic outcome was assessed on acetabular cup version (hip) and acetabular cup inclination and reported in this outcome measure. | Per protocol population set consisted of all participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. Here, 'N'(number of participants analyzed)=who were evaluable for this outcome measure, 'n'(number analyzed)=participant who were evaluated at specified timepoint. | Posted | Mean | Standard Deviation | Degrees | Weeks 6 and 24 (post-operative) |
|
|
|
| Secondary | Length of Hospital Stay After Index Total Hip Arthroplasty (THA) | Length of hospital stay (in days) after index THA was calculated from date of discharge minus date of surgery. | Per protocol population set consisted of all enrolled participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. | Posted | Mean | Standard Deviation | Days | From operative day (Day 0) to date of discharge (any time from Day 0 to Day 5) |
|
|
|
| Secondary | Number of Participants With Re-hospitalization During the Study | Number of participants with re-hospitalizations during the study was reported. | Per protocol population set consisted of all enrolled participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. | Posted | Count of Participants | Participants | Day 0 (operative day) to Day 90 (post-operative) |
|
|
|
| Secondary | Number of Participants With Narcotic Pain Medication Usage | Number of participants who received any narcotic pain medication to manage study hip pain was reported. | Per protocol population set consisted of all enrolled participants who successfully received planned treatment, who met all inclusion/exclusion criteria, who were seen at least once at post-operative visit, who did not had any protocol deviation which were prospectively determined to potentially had influence on scientific validity of data. | Posted | Count of Participants | Participants | From post operation (Day 0) to Week 24 |
|
|
|
| Secondary | Number of Participants With Post-operative Complications | Number of participants who experienced post-operative complication was reported. | The safety population set consisted of all participants in the enrolled population set for whom treatment was attempted, according to the actual treatment received. | Posted | Count of Participants | Participants | Day 0 (operative day) up to Week 24 |
|
|
|
| 0 |
| 117 |
| 0 |
| 117 |
| 21 |
| 117 |
| EG001 | Arm 2: MALLET | Participants indicated to receive primary uncemented THA underwent Anterior Advantage approach in THA using MALLET (a surgical hammer like instrument, without KINCISE surgical automated system). | 1 | 111 | 3 | 111 | 8 | 111 |
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA Version 22.0 | Systematic Assessment |
|
| Cerebrovascular accident | Nervous system disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Groin pain | Musculoskeletal and connective tissue disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Joint stiffness | Musculoskeletal and connective tissue disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Joint swelling | Musculoskeletal and connective tissue disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Musculoskeletal discomfort | Musculoskeletal and connective tissue disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Tendonitis | Musculoskeletal and connective tissue disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Extraskeletal ossification | Injury, poisoning and procedural complications | MedDRA Version 22.0 | Systematic Assessment |
|
| Fall | Injury, poisoning and procedural complications | MedDRA Version 22.0 | Systematic Assessment |
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA Version 22.0 | Systematic Assessment |
|
| Muscle strain | Injury, poisoning and procedural complications | MedDRA Version 22.0 | Systematic Assessment |
|
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA Version 22.0 | Systematic Assessment |
|
| Cerebrospinal fluid leakage | Nervous system disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Meralgia paraesthetica | Nervous system disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Paraesthesia | Nervous system disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Swelling | General disorders | MedDRA Version 22.0 | Systematic Assessment |
|
| Peripheral swelling | General disorders | MedDRA Version 22.0 | Systematic Assessment |
|
Draft abstracts, manuscripts, and materials for presentation at scientific meetings must be sent to the sponsor at least 60 working days prior to abstract or other relevant submission deadlines. Authorship of publications resulting from this study was based on generally accepted criteria for major medical journals.
| D003240 |
| Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| Week 24 |
|
|
| Week 24 |
|
|
| Week 24 |
|
|
| Mild |
|
| Moderate |
|
| Severe |
|
| Missing |
|
| Week 24: Groin pain |
|
|
| Week 6: Buttock pain |
|
|
| Week 24: Buttock pain |
|
|
| Very satisfied |
|
| Moderately satisfied |
|
| Slightly satisfied |
|
| Not at all satisfied |
|
| Missing |
|
| Week 24 |
|
|
| Do you drive? |
|
|
| Can you perform basic activities of daily living without assistance? |
|
|
| Can you perform light household duties? |
|
|
| Can you perform moderate to heavy household duties? |
|
|
| Can you go up and down a flight of stairs using a handrail? |
|
|
| Can you put on socks/stockings without someone's assistance? |
|
|
| Can you bend down to pick up an object on the floor? |
|
|
| Can you stand up from a chair without assistance? |
|
|
| Can you participate in leisure recreational activities? |
|
|
| Do you work? |
|
|
| When were you first able to accomplish primary goal you identified after surgery? |
|
|
| Week 24: Acetabular Cup Migration: Absent |
|
|
| Week 6: Acetabular Cup Radiolucency: Present |
|
|
| Week 6: Acetabular Cup Radiolucency: Absent |
|
|
| Week 24: Acetabular Cup Radiolucency: Present |
|
|
| Week 24: Acetabular Cup Radiolucency: Absent |
|
|
| Week 24: Acetabular Cup Progressive Radiolucency: Present |
|
|
| Week 24: Acetabular Cup Progressive Radiolucency: Absent |
|
|
| Week 24: Acetabular Cup Osteolysis: Present |
|
|
| Week 24: Acetabular Cup Osteolysis: Absent |
|
|
| Week 6: Acetabular Cup Sclerotic Lines: Present |
|
|
| Week 6: Acetabular Cup Sclerotic Lines: Absent |
|
|
| Week 24: Acetabular Cup Sclerotic Lines: Present |
|
|
| Week 24: Acetabular Cup Sclerotic Lines: Absent |
|
|
| Week 6: Acetabular Cup Porous Coating Integrity: Present |
|
|
| Week 6: Acetabular Cup Porous Coating Integrity: Absent |
|
|
| Week 24: Acetabular Cup Porous Coating Integrity: Present |
|
|
| Week 24: Acetabular Cup Porous Coating Integrity: Absent |
|
|
| Week 24: Femoral Stem Subsidence: Present |
|
|
| Week 24: Femoral Stem Subsidence: Absent |
|
|
| Week 6: Femoral Stem Radiolucency: Present |
|
|
| Week 6: Femoral Stem Radiolucency: Absent |
|
|
| Week 24: Femoral Stem Radiolucency: Present |
|
|
| Week 24: Femoral Stem Radiolucency: Absent |
|
|
| Week 24: Femoral Stem Osteolysis: Present |
|
|
| Week 24: Femoral Stem Osteolysis: Absent |
|
|
| Week 6: Calcar Resorption: Present |
|
|
| Week 6: Calcar Resorption: Absent |
|
|
| Week 24: Calcar Resorption: Present |
|
|
| Week 24: Calcar Resorption: Absent |
|
|
| Week 6: Calcar Fracture: Present |
|
|
| Week 6: Calcar Fracture: Absent |
|
|
| Week 24: Calcar Fracture: Present |
|
|
| Week 24: Calcar Fracture: Absent |
|
|
| Week 24: Femoral stem tilt: Present |
|
|
| Week 24: Femoral stem tilt: Absent |
|
|
| Week 24: Femoral stem tilt: Not applicable |
|
|
| Week 6: Femoral Stem Porous Coating Integrity: Present |
|
|
| Week 6: Femoral Stem Porous Coating Integrity: Absent |
|
|
| Week 6: Femoral Stem Porous Coating Integrity: Not applicable |
|
|
| Week 24: Femoral Stem Porous Coating Integrity: Present |
|
|
| Week 24: Femoral Stem Porous Coating Integrity: Absent |
|
|
| Week 24: Femoral Stem Porous Coating Integrity: Not applicable |
|
|
| Week 6: Varus |
|
|
| Week 6: Valgus |
|
|
| Week 24: Neutral |
|
|
| Week 24: Varus |
|
|
| Week 24: Valgus |
|
|
| Week 6: Non-intact |
|
|
| Week 24: Intact |
|
|
| Week 24: Non-intact |
|
|
| Week 6: Class I |
|
|
| Week 6: Class II |
|
|
| Week 6: Class III |
|
|
| Week 6: Class IV |
|
|
| Week 24: Class 0 |
|
|
| Week 24: Class I |
|
|
| Week 24: Class II |
|
|
| Week 24: Class III |
|
|
| Week 24: Class IV |
|
|
| Week 24: Acetabular Cup Version: Hip |
|
|
| Week 6: Acetabular Cup Inclination |
|
|
| Week 24: Acetabular Cup Inclination |
|
|